Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ
FASIGYN 500mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. White, round, biconvex film-coated tablet embossed on one side with “FAS 500”. |
Tinidazole 500mg.
| Active Ingredient | Description | |
|---|---|---|
| Tinidazole |
Tinidazole is active against both protozoa and obligate anaerobic bacteria. The activity against protozoa involves Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. The mode of action of tinidazole against anaerobic bacteria and protozoa involves penetration of the drug into the cell of the micro-organism and subsequent damage of DNA strands or inhibition of their synthesis. |
| List of Excipients |
|---|
|
Tablet Core: Microcrystalline cellulose (Avicel PH 101) Film Coating: Hydroxypropyl methyl cellulose |
Aluminium foil backed blister packs of 16 500mg tablets consisting of:
a) 250 micron PVC blister coated with 40gsm of PVdC
b) 20 micron aluminium foil backing coated with 20gsm PVdC
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ
PL 00057/0150
08/02/2006
| Drug | Countries | |
|---|---|---|
| FASIGYN | Mexico, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
